Brock N, Hilgard P, Pohl J, Ormstad K, Orrenius S
J Cancer Res Clin Oncol. 1984;108(1):87-97. doi: 10.1007/BF00390979.
A number of thiol compounds have been studied with reference to their selective protective action against urotoxic side-effects of oxazaphosphorine cytostatics. The uroprotective capacity is determined exclusively by the pharmacokinetic behavior of the compound. When given PO, all compounds tested were absorbable from the gut. Both thiols and disulfides are rapidly eliminated from the blood, but during their short half-life a number of unknown chemical reactions probably take place to maintain a physiological redox equilibrium. Elimination from the blood plasma occurs via two fundamentally different mechanisms: by distribution throughout the tissues and intracellular uptake or, alternatively, by rapid renal excretion. Most of the compounds tested belong to the first group: N-acetylcysteine, carboxycysteine, disulfiram and its metabolite DDTC, glutathione, WR 2721, etc. Few compounds are quantitatively excreted through the urine: mesna, dimesna, and DA 12. Only these compounds were suitable for selective regional detoxification and for the prevention of oxazaphosphorine-induced urotoxic lesions.
已经对多种硫醇化合物进行了研究,以探讨它们对氧氮磷啶类细胞抑制剂的泌尿毒性副作用的选择性保护作用。泌尿保护能力完全由化合物的药代动力学行为决定。口服给药时,所有测试的化合物都可从肠道吸收。硫醇和二硫化物都能迅速从血液中消除,但在它们较短的半衰期内,可能会发生一些未知的化学反应以维持生理氧化还原平衡。血浆中的消除通过两种根本不同的机制进行:通过分布到整个组织和细胞内摄取,或者通过快速肾脏排泄。大多数测试的化合物属于第一组:N-乙酰半胱氨酸、羧基半胱氨酸、双硫仑及其代谢产物二乙基二硫代氨基甲酸钠、谷胱甘肽、WR 2721等。很少有化合物通过尿液定量排泄:美司钠、二巯基丁二酸钠和DA 12。只有这些化合物适用于选择性区域解毒和预防氧氮磷啶引起的泌尿毒性损伤。